Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukherji

Showing results (1091-1100 of 1,112) with videos related to

Pageof 112
Sort By:
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
The Oncologist|October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global surveyEnrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
JCO Global Oncology|June 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Human Gene Therapy|December 29, 2025
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II MiceWanida Ruangsiriluk, Sarah Melissa P Jacobo, Andrea Iskenderian, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
World Journal of Urology|July 13, 2019
Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendationsDeborah Mukherji, Bassem Youssef, Christelle Dagher, et al.
Healthcare (Basel, Switzerland)|November 11, 2022
Fighting Cancer around the World: A Framework for ActionDenis Horgan, Rizwana Mia, Tosan Erhabor, et al.
Pageof 112

Showing results (1091-1100 of 1,112) with videos related to

Sort By:
Pageof 112
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
The Oncologist|October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global surveyEnrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
JCO Global Oncology|June 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Human Gene Therapy|December 29, 2025
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II MiceWanida Ruangsiriluk, Sarah Melissa P Jacobo, Andrea Iskenderian, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
World Journal of Urology|July 13, 2019
Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendationsDeborah Mukherji, Bassem Youssef, Christelle Dagher, et al.
Healthcare (Basel, Switzerland)|November 11, 2022
Fighting Cancer around the World: A Framework for ActionDenis Horgan, Rizwana Mia, Tosan Erhabor, et al.
Pageof 112